Haplotyping and copy number estimation of the highly polymorphic human beta-defensin locus on 8p23 by 454 amplicon sequencing.
BACKGROUND
The beta-defensin gene cluster (DEFB) at chromosome 8p23.1 is one of the most copy number (CN) variable regions of the human genome. Whereas individual DEFB CNs have been suggested as independent genetic risk factors for several diseases (e.g. psoriasis and Crohn's disease), the role of multisite sequence variations (MSV) is less well understood and to date has only been reported for prostate cancer. Simultaneous assessment of MSVs and CNs can be achieved by PCR, cloning and Sanger sequencing, however, these methods are labour and cost intensive as well as prone to methodological bias introduced by bacterial cloning. Here, we demonstrate that amplicon sequencing of pooled individual PCR products by the 454 technology allows in-depth determination of MSV haplotypes and estimation of DEFB CNs in parallel.


RESULTS
Six PCR products spread over approximately 87 kb of DEFB and harbouring 24 known MSVs were amplified from 11 DNA samples, pooled and sequenced on a Roche 454 GS FLX sequencer. From approximately 142,000 reads, approximately 120,000 haplotype calls (HC) were inferred that identified 22 haplotypes ranging from 2 to 7 per amplicon. In addition to the 24 known MSVs, two additional sequence variations were detected. Minimal CNs were estimated from the ratio of HCs and compared to absolute CNs determined by alternative methods. Concordance in CNs was found for 7 samples, the CNs differed by one in 2 samples and the estimated minimal CN was half of the absolute in one sample. For 7 samples and 2 amplicons, the 454 haplotyping results were compared to those by cloning/Sanger sequencing. Intrinsic problems related to chimera formation during PCR and differences between haplotyping by 454 and cloning/Sanger sequencing are discussed.


CONCLUSIONS
Deep amplicon sequencing using the 454 technology yield thousands of HCs per amplicon for an affordable price and may represent an effective method for parallel haplotyping and CN estimation in small to medium-sized cohorts. The obtained haplotypes represent a valuable resource to facilitate further studies of the biomedical impact of highly CN variable loci such as the beta-defensin locus.
Taudien
Stefan
S
Leibniz Institute for Age Research-Fritz Lipmann Institute, Jena, Germany. stau@fli-leibniz.de
Groth
Marco
M
Huse
Klaus
K
Petzold
Andreas
A
Szafranski
Karol
K
Hampe
Jochen
J
Rosenstiel
Philip
P
Schreiber
Stefan
S
Platzer
Matthias
M
D002898:Chromosomes, Human, Pair 8; D056915:DNA Copy Number Variations; D006239:Haplotypes; D006801:Humans; D005810:Multigene Family; D017422:Sequence Analysis, DNA / Q000379:methods*; D023083:beta-Defensins / Q000235:genetics*
D023083:beta-Defensins
BMC Genomics. 2009 Nov 20;10:547
19930547
Nat Genet. 2004 Aug;36(8):861-6
15247918
Hum Mutat. 2008 Oct;29(10):1247-54
18470942
Plant Biotechnol J. 2009 May;7(4):347-54
19386042
PLoS One. 2007 Feb 14;2(2):e197
17299583
Nature. 2005 Sep 15;437(7057):376-80
16056220
BMC Genomics. 2004 Dec 10;5(1):92
15588320
Cytogenet Genome Res. 2008;123(1-4):148-55
19287149
Biotechniques. 2009 Dec;47(6):1023-8
20041854
Nat Genet. 2009 Oct;41(10):1061-7
19718026
BMC Genomics. 2009 Nov 25;10:559
19939274
Biotechniques. 1998 Oct;25(4):684-91
9793653
Am J Hum Genet. 2006 Sep;79(3):439-48
16909382
Genes Cells. 2009 Jan;14(1):69-77
19077033
Am J Gastroenterol. 2010 Feb;105(2):354-9
19809410
Biotechniques. 2009 Mar;46(3):217-23
19317665
Nucleic Acids Res. 2002 Jun 15;30(12):e57
12060695
Nucleic Acids Res. 2007;35(3):e19
17175532
PLoS One. 2009 Jul 20;4(7):e6285
19617917
Proc Natl Acad Sci U S A. 2009 Jan 20;106(3):853-8
19131514
Anal Biochem. 2006 Sep 15;356(2):194-201
16737678
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1886-91
19181860
Hum Mutat. 2009 Mar;30(3):472-6
19058222
J Negat Results Biomed. 2005 Dec 07;4:9
16336654
Genome Biol. 2009;10(5):R53
19457243
Genome Res. 2008 Nov;18(11):1686-97
18974263
Nucleic Acids Res. 2009 Nov;37(20):6916-26
19740768
Nucleic Acids Res. 1997 Nov 1;25(21):4422-6
9336479
Nucleic Acids Res. 2009 Feb;37(2):e12
19059995
Biotechniques. 2009 Oct;47(4):857-66
19852769
Tumour Biol. 2008;29(2):83-92
18515986
Genomics. 2005 Oct;86(4):423-30
16039093
Proc Natl Acad Sci U S A. 2009 Sep 22;106(38):16333-8
19805302
Science. 2006 Nov 17;314(5802):1113-8
17110569
Nat Genet. 2008 Jan;40(1):23-5
18059266
Mucosal Immunol. 2008 Nov;1 Suppl 1:S67-74
19079235
Science. 2007 Oct 19;318(5849):441-4
17901299
Eur J Gastroenterol Hepatol. 2003 Jun;15(6):627-34
12840673
Genome Biol. 2009;10(9):R94
19747388
Am J Hum Genet. 2003 Sep;73(3):591-600
12916016
Nat Med. 2006 Jul;12(7):852-5
16799556
J Immunol Methods. 2006 Jan 20;308(1-2):231-40
16380128
Expert Rev Anti Infect Ther. 2007 Dec;5(6):1049-57
18039087
Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3521-6
18303113
Nature. 2003 Dec 18;426(6968):789-96
14685227
Immunogenetics. 2008 Jan;60(1):1-18
18193213
Nat Rev Immunol. 2003 Sep;3(9):710-20
12949495